Bioenergetics of murine lungs infected with respiratory syncytial virus

Virology Journal

Volumn 10, Issue , 2013, Pages

  Alsuwaidi, Ahmed R ^a   Benedict, Sheela ^a   Kochiyil, Jose ^a   Mustafa, Farah ^a   Hartwig, Stacey M ^b   Almarzooqi, Saeeda ^a   Albawardi, Alia ^a   Rizvi, Tahir A ^a   Varga, Steven M ^b,c   Souid, Abdul Kader ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Caspases; Cellular ATP; Cellular respiration; Mitochondria; Oxygen consumption; Respiratory syncytial virus (RSV)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BREATHING; CELL RESPIRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHIBITION KINETICS; INOCULATION; LUNG INFECTION; MALE; MOUSE; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION; PHOSPHORESCENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CASPASE 3; ENERGY METABOLISM; FEMALE; HUMANS; LUNG; MALE; MICE; MICE, INBRED BALB C; OXYGEN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84872127069     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-22     Document Type: Article

References (35)

1. Respiratory syncytial virus infections: old challenges and new opportunities. Mejias A, Chavez-Bueno S, Jafri HS, Ramilo O, Pediatr Infect Dis J 2005 24 11 Suppl 189 discussion S96-7 16378045
2. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. Beckham JD, Cadena A, Lin J, Piedra PA, Glezen WP, Greenberg SB, et al. J Infect 2005 50 322 330 10.1016/j.jinf.2004.07.011 15845430
3. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. Welliver RC, J Pediatr 2003 143 112 S117 10.1067/S0022-3476(03)00508-0 14615709
4. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Mohapatra SS, Boyapalle S, Clin Microbiol Rev 2008 21 495 504 10.1128/CMR.00054-07 18625684
5. Respiratory syncytial virus and metapneumovirus. Collins PL, Crowe JE, Knipe DM, Howley PM, et al. Fields virology Philadelphia, PA: Lippincott Williams & Wilkins, Knipe DM, 5 2006 1601 1646
6. Molecular epidemiology of respiratory syncytial virus. Cane PA, Rev Med Virol 2001 11 103 116 10.1002/rmv.305 11262529
7. Junge S, Nokes DJ, Simoes EAF, Weber MW, Respiratory syncytial virus City, state: Elsevier Inc 2008 561 571
8. Pathogenesis of respiratory syncytial virus. van Drunen S, van den Hurk L, Watkiss ER, Curr Opinion Virol 2012 2 300 305 10.1016/j.coviro.2012.01.008
9. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, Lee S, Goleniewska K, Pretto C, Williams JV, Hotard A, Sherrill TP, Peebles RS, Moore MM, J Virol 2011 85 5782 5793 10.1128/JVI.01693-10 21471228
10. Respiratory syncytial virus and parainfluenza virus. Hall CB, N Engl J Med 2001 344 1917 1928 10.1056/NEJM200106213442507 11419430
11. Animal models of human respiratory syncytial virus disease. Bem RA, Domachowske JB, Rosenberg HF, Am J Physiol Lung Cell Mol Physiol 2011 301 2 148 156 10.1152/ajplung.00065.2011
12. The role of RSV infection in asthma initiation and progression: findings in a mouse model. Han J, Takeda K, Gelfand EW, Pulmonary Med 2011 doi:10.1155/2011/748038
13. New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. Boya P, Roques B, Kroemer G, EMBO J 2001 15 4325 4331
14. The role of mitochondria in cellular defense against microbial infection. Arnoult D, Carneiro L, Tattoli I, Girardin SE, Semin Immunol 2009 21 223 232 10.1016/j.smim.2009.05.009 19535268
15. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1β-converting enzyme gene expression but does not cause apoptosis. Takeuchi R, Tsutsumi H, Osaki M, Haseyama K, Mizue N, Chiba S, J Virol 1998 72 4498 4502 9557748
16. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. O'Donnell DR, Milligan L, Stark JM, Virology 1999 257 198 207 10.1006/viro.1999.9650 10208933
17. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. Bitko V, Barik S, J Cell Biochem 2001 80 441 454 10.1002/1097- 4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C 11135374
18. Respiratory syncytial virus infection induces expression of the anti-apoptosis gene IEX-1L in human respiratory epithelial cells. Domachowske JB, Bonville CA, Mortelliti AJ, Colella CB, Kim U, Rosenberg HF, J Infect Dis 2000 181 824 830 10.1086/315319 10720500
19. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev AJ, Virology 2003 77 9156 72 10.1128/JVI.77.17.9156-9172.2003
20. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW, J Biol Chem 2002 277 492 501 11687577
21. The pathophysiology of mitochondrial cell death. Green DR, Kroemer G, Science 2004 305 626 629 10.1126/science.1099320 15286356
22. Caspase activation by cytotoxic drugs (the caspase storm). Tao Z, Penefsky HS, Goodisman J, Souid A-K, Mol Pharm 2007 4 583 595 10.1021/mp070002r 17439154
23. Measurement of oxygen consumption by murine tissues in vitro. Al Samri MT, Al Shamsi M, Al-Salam S, Marzouqi F, Al Mansouri A, Al-Hammadi S, Balhaj G, Al Dawaar SK, Al Hanjeri RS, Benedict S, Sudhadevi M, Conca W, Penefsky HS, Souid A-K, J Pharmacol Toxicol Meth 2011 63 196 204 10.1016/j.vascn.2010.10.002
24. Biocompatibility study of mesoporous silicate particles with cellular bioenergetics in murine tissues. Al-Shamsi M, Al-Samri M, Al-Salam S, Conca W, Benedict S, Sudhadevi M, Biradar A, Asefa T, Souid A-K, Chem Res Toxicol 2010 11 1796 1805
25. In vitro study of calcined mesoporous silica nanoparticles in mouse lung. Al-Salam S, Balhaj G, Al-Hammadi S, Sudhadevi M, Tariq S, Biradar AV, Asefa T, Souid A-K, Toxicology Sciences 2011 122 86 99 10.1093/toxsci/kfr078
26. Oxygen measurements via phosphorescence. Shaban S, Marzouqi F, Al Mansouri A, Penefsky H, Souid AK, Computer Meth Programs Biomed 2010 100 265 268 10.1016/j.cmpb.2010.04.009
27. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. Olsen MR, Varga SM, J Immunol 2007 179 5415 5424 17911628
28. Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine: A phosphor with general application for measuring oxygen concentration in biological systems. Lo LW, Koch CJ, Wilson DF, Anal Biochem 1996 236 153 160 10.1006/abio.1996.0144 8619481
29. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC, J Clin Microbiol 1998 36 2990 2995 9738055
30. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. Fulton RB, Meyerholz DK, Varga SM, J Immunol 2010 185 2382 2392 10.4049/jimmunol.1000423 20639494
31. The virus as metabolic engineer. Maynard ND, Gutschow MV, Birch EW, Covert MW, Biotechnol J 2010 5 686 694 10.1002/biot.201000080 20665642
32. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus. Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S, Am J Respir Crit Care Med 2006 15 173 673 682
33. Hepatitis C virus hijacks host lipid metabolism. Syed GH, Amako Y, Siddiqui A, Trends Endocrinol Metab 2010 21 33 40 10.1016/j.tem.2009.07.005 19854061
34. Modulation of host metabolism as a target of new antivirals. Ikeda M, Kato N, Adv Drug Deliv Rev 2007 10 59(12) 1277 1289
35. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Chávez-Bueno S, Mejías A, Gómez AM, Olsen KD, Ríos AM, Fonseca-Aten M, Ramilo O, Jafri HS, Virol J 2005 2 46 10.1186/1743-422X-2-46 15916706